• Home >>
  • Pharmaceuticals and Healthcare >>
  • Scleroderma Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

Scleroderma Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

ID: 240274 21st May, 2018 Region : Global Pages
Covid-19

COVID-19

Understand the influence of COVID-19 on the Scleroderma Market with our analysts monitoring the situation across the globe.

Global Scleroderma Market by Drugs (Corticosteroids, Immunosuppressive Agents, Endothelin Receptor Agonists, Calcium Channel Blockers, Prostacyclin Analogues and others), by Indication (Localized and Systematic), by Mode of Test Type (Skin Biopsy, Imaging Techniques, Blood Tests, Pulmonary Function Tests, Electrocardiogram and Echocardiogram)-Global Forecast Till 2025.


Market Scenario
Scleroderma is a skin disease which means hardening of skin. It is two forms of disease which includes chronic connective tissue disease and rheumatic disease. Chronic connective tissue disease that negatively affects tissues which include tendon, skin and cartilage and differs from patient to patient and rheumatic disease is recognised by pain in muscles and inflammation.  Scleroderma is of two main types which include localized and systemic. The systemic type of scleroderma can have affect on any part of the body including blood vessels, skin and internal organs.  The localized type of scleroderma is linear and morphea which can affect only the skin and do not affect the internal organs. 


Rising number of patients of scleroderma and rising prevalence of genetic mutations are the major drivers that are fuelling the growth in the scleroderma market. However, high cost of drugs and additional cost due to research & development of drugs are the main factors that may impede the growth of the market. On the other hand, the introduction of new medical solutions and high unmet medical needs associated with scleroderma are the important factors that have created future growth opportunities.


Segmentation
On the basis of drugs, market is segmented into Corticosteroids, Immunosuppressive Agents, Endothelin Receptor Agonists, Calcium Channel Blockers, Prostacyclin Analogues and others. On the basis of indication, market is segmented into localized and systematic. On the basis of mode of test type, market is segmented into skin biopsy, imaging techniques, blood tests, pulmonary function tests, electrocardiogram and echocardiogram.


Regional Analysis

Geographically, the global scleroderma market can be analysed into North America, Asia-Pacific, Europe and LAMEA.  Better diagnostic treatment available, proactive awareness due to several foundations associated with healthcare disease are the factors that have driven the growth of the market in North America and Europe.  In addition, presence of prominent pharmaceutical companies, medical institutes in the developing countries and research organisation are emphasized on finding a standard treatment. Moreover, Asia Pacific market is driven factors such as emerging economies, high adoption of new therapies at reasonable costs are the important factor that has anticipated the growth of the market.


Key Drivers
Major key players in the market are Actelion Pharmaceuticals, Inc, Bayer AG, Corbus Pharmaceutical Holdings Inc., Boehringer Ingelheim, Cytori Therapeutics, Inc., Pfizer, Inc., Sanofi, Cumberland Pharmaceuticals, Inc.  and Gilead Sciences, Inc. 


Segmentation


• By Drugs
o Corticosteroids
o Immunosuppressive Agents
o Endothelin Receptor Agonists 
o Calcium Channel Blockers 
o Prostacyclin Analogues 
o Others


• By Indication
o Localized 
o Systematic


• By Mode of Test Type
o Skin Biopsy 
o Imaging Techniques
o Blood Tests
o Pulmonary Function Tests 
o Electrocardiogram  
o Echocardiogram


Research Scope

 The study for Schleroderma Market will provide market size, estimates and forecast based on the following years: 
 

Historic data: 2015  Base Year Estimate: 2016  Forecast: 2017 to 2025
The report has been categorized in two distinctive sections, where the first category titled as Market Overview provides a holistic view of the market, key trends, drivers, challenges/restraints or opportunities with their current and expected impact on the overall industry sales. 


Our analyst implement, several qualitative tools to interpret and represent key industry findings. 
The second section of the study provides market size, estimates and forecast for key market segments and regional market. The final part of the report highlights key manufacturers/vendors operating in the associated market. 


1. Introduction
1.1. Market Definition
1.2. Market Scope


2. Research Methodology
2.1. Primary Research
2.2. Secondary Sources
2.3. Assumptions & Exclusions


3. Market Overview
3.1. Research Report Segmentation & Scope
3.2. Schleroderma- Value Chain Analysis 
3.3. Key Market Trend Analysis
3.3.1. Market Drivers
3.3.2. Market Restraint/Challenges
3.3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Potential Venture Avenues
3.6. Market Share Analysis, 2016 
3.7. Market Overview – Schleroderma, Product Landscape


4. Segmentation Overview
4.1. Introduction 
4.2. Market Size & Forecast, 2015 to 2025
4.2.1. By Drugs
4.2.1.1. Corticosteroids
4.2.1.2. Immunosuppressive Agents
4.2.1.3. Endothelin Receptor Agonists 
4.2.1.4. Calcium Channel Blockers 
4.2.1.5. Prostacyclin Analogues 
4.2.1.6. Others
4.2.2. By Indication
4.2.2.1. Localized
4.2.2.2. Systematic
4.2.3. By Mode of Test Type
4.2.3.1. Skin Biopsy 
4.2.3.2. Imaging Techniques
4.2.3.3. Blood Tests
4.2.3.4. Pulmonary Function Tests 
4.2.3.5. Electrocardiogram
(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


5. Regional Overview
5.1. Introduction
5.2. Market Size & Forecast, 2015 to 2025
5.2.1. North America 
5.2.1.1. U.S.
5.2.1.2. Canada
5.2.1.3. Mexico
5.2.2. Europe
5.2.2.1. UK
5.2.2.2. Germany
5.2.2.3. France
5.2.2.4. Italy
5.2.2.5. Spain
5.2.2.6. Rest of Europe
5.2.3. Asia Pacific
5.2.3.1. China
5.2.3.2. India
5.2.3.3. Japan
5.2.3.4. Australia
5.2.3.5. South Korea
5.2.3.6. Rest of Asia Pacific 
5.2.4. LAMEA
5.2.4.1. Brazil
5.2.4.2. UAE
5.2.4.3. South Africa
5.2.4.4. Rest of LAMEA 
 (Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


6. Manufacturer/ Vendor Profile
6.1. The following attributes will be considered while profiling key manufacturers in this industry: 
6.1.1. Company Overview
6.1.2. Financial Synopsis
6.1.3. Recent Developments
6.1.4. R&D Investments (if any)
6.1.5. Strategy Overview (Analyst Perspective)
6.1.6. Product Portfolio
6.2. Companies Profiled
6.2.1. Actelion Pharmaceuticals, Inc 
6.2.2. Bayer AG
6.2.3. Corbus Pharmaceutical Holdings Inc.
6.2.4. Boehringer Ingelheim
6.2.5. Cytori Therapeutics, Inc.
6.2.6. Pfizer, Inc. 
6.2.7. Sanofi
6.2.8. Cumberland Pharmaceuticals, Inc.
6.2.9. Gilead Sciences, Inc. 

 (Note: The companies mentioned above are tentative in nature, and profiles of other market players not listedhere can be included on request.)

Request COVID-19 Impact Analysis

We understand the economic repercussions of the pandemic and are dedicated towards helping our clients strategize with rapidly changing market scenario,
• Impact of COVID on supply/demand scenario, trade landscape & supply chain
• How market participants are preparing/strategizing to combat the impact
• How does the short-term & long-term scenario for Scleroderma Market looks like

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Request Sample

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Request Discount

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Related Reports




Get 15 minutes of free Consultation When you request a Sample Report!

24/7 Research Report

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone:

+1 513 549 5911 (US)

+44 203 318 2846 (UK)

Email: [email protected]

Request a Sample

Scleroderma Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

Report ID :240274

Published Date :21st May, 2018

Category :Pharmaceuticals and Healthcare

Pages : Pages

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports

  • Data Security
  • Your data is safe and secure

  • Vast Report Database
  • We have more than 2 Million reports in our database

  • Client Focused
  • Personalized updates and 24*7 support

  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support

  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie

  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports


Every Sample Will Help to Understand

  • Report Structure and Outline
  • Detailed Table of Content (Including List of Tables and Figures)
  • Research Methodology